Keyphrases
Poliovirus Receptor
100%
CD155
100%
NIH3T3
45%
Cell Proliferation
27%
Immunoreceptor Tyrosine-based Activation Motif
18%
Necl-5
18%
Overexpression
9%
Knockdown
9%
Cell-cell Junctions
9%
Platelet-derived Growth factor-BB (PDGF-BB)
9%
Small Interfering RNA (siRNA)
9%
ERK Pathway
9%
Dominant Negative
9%
Cell Adhesion
9%
Cell Migration
9%
KRAS mutation
9%
K-ras
9%
G1 Phase
9%
P27Kip1
9%
Cell Matrix
9%
Cyclin D2 (CCND2)
9%
Focal Adhesion Kinase
9%
Cytoplasmic Area
9%
HT-1080 Cells
9%
RAS Gene
9%
N-Ras
9%
G(0)
9%
Raf-MEK-ERK
9%
Adherence Junction
9%
Oncogenic Ras
9%
DLD-1 Cells
9%
Neuroscience
CD155
100%
Poliovirus
100%
Receptor
100%
Cell Proliferation
27%
Immunoreceptor Tyrosine Based Inhibition Motif
18%
Oncogene Ras
18%
Cell Signaling
9%
Cell Migration
9%
Small Interfering RNA
9%
Platelet-Derived Growth Factor
9%
Cell Adhesion
9%
Extracellular Matrix
9%
Cell Cycle
9%
Cell Cycle G1 Phase
9%
Focal Adhesion Kinase
9%
Cyclin D2
9%
Janus Kinase 1
9%
Biochemistry, Genetics and Molecular Biology
CD155
100%
Poliomyelitis Virus
100%
Cell Proliferation
27%
Oncogene Ras
18%
Immunoreceptor Tyrosine-Based Inhibitory Motif
18%
Cell Junction
9%
Cell Migration
9%
Platelet-Derived Growth Factor
9%
Cell Cycle
9%
Signal Transduction
9%
Cell Adhesion
9%
Small Interfering RNA
9%
Cyclin D2
9%
G1 Phase
9%
Janus Kinase 1
9%
Immunology and Microbiology
Poliomyelitis Virus
100%
CD155
100%
Cell Proliferation
27%
Oncogene Ras
18%
Immunoreceptor Tyrosine-Based Inhibitory Motif
18%
Cell Junction
9%
Platelet Derived Growth Factor
9%
Cell Migration
9%
Signal Transduction
9%
Cell Adhesion
9%
Cell Cycle
9%
Extracellular Matrix
9%
Cell Cycle G1 Phase
9%
Focal Adhesion
9%
Cyclin D2
9%